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A report on the Advances in Genome Biology and
Technology meeting held in Marco Island, Florida,
USA, on February 12–15, 2014.The annual Advances in Genome Biology and Technology
(AGBT) meeting in Marco Island, Florida, is the pre-
eminent venue for cutting edge, high-throughput sequen-
cing technology and applications. As such, it is a hot
ticket, and the meeting was oversubscribed with about
300 posters and talks, and more than 800 attendees, des-
pite the awful travel conditions that ensnared many in the
iced-in East Coast airports.
The incredible improvements in sequencing technol-
ogy have been often noted, but the shocking pace of this
progress bears yet another mention: simply put, the
greater than six order-of-magnitude improvement in se-
quencing cost per base seen in the last 12 or so years is un-
precedented in the history of the development of any
technology. Much of this incredible progress was seeded by
strategic investments by the National Institutes of Health’s
(NIH) National Human Genome Research Institute
(NHGRI). A stirring platform presentation from Jeff
Schloss (NHGRI, NIH, USA) provided a historical back-
drop for the current ‘perpetual revolution’ in sequencing
by outlining the contributions of the NIH’s $100,000 and
$1,000 genome initiatives. From 454 to the Polonator,
from SOLiD to Helicos, from Ion Torrent to Advanced
Liquid Logic, Jeff memorably recounted how the NHGRI-
sponsored requests for application helped to drive the
innovation that has powered the genomics revolution.
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unless otherwise stated.focused on new frontiers in application of existing tech-
nologies. However, there were several notable presenta-
tions that focused on other sequencing technologies,
underscoring that even Illumina’s powerful machines are
not sufficient to cover all applications or use cases.Technologies: one of these things is not like the
other?
Perhaps PacBio would have been well advised to have
saved the fireworks it sent into the Florida skies in 2008
for this year. Several talks focused on how PacBio-based
or PacBio-assisted methods result in higher quality as-
semblies or gene models than traditional Sanger or more
recent Illumina-only approaches. For example, Dick
McCombie (Cold Spring Harbor, USA) showed a new
PacBio-only yeast genome assembly, David Wheeler
(Baylor College of Medicine, USA) presented structural
variant discovery in cancer, and Sean McGrath (Washington
University School of Medicine, USA) discussed how
cDNA-based PacBio reads greatly improve transcript
annotation. If these applications are portents of the future,
we may need to prepare for the coexistence of Illumina
with a long-read technology for some years to come. But
will this long-read technology come from PacBio or
Oxford Nanopore?
Oxford Nanopore technology uses a protein nanopore
and a synthetic membrane to measure conductance
changes as single-stranded DNA is ratcheted through the
pore. A base calling algorithm then interprets these
changes in conductance to identify six-mer sequences
present within the pore during the transit, thereby recon-
structing the sequences of individual long molecules of
DNA. Oxford Nanopore’s technology was presented by
David Jaffe, leader of the genome computation group at
the Broad Institute. As Jaffe repeatedly pointed out, the
raw data on two bacterial genomes was generated by
the Broad group and the base-calling was performed by
Oxford Nanopore, who sent the reads back to Jaffe. Jaffe
used the data to resolve ambiguities in Illumina-only
assemblies. The reads provided by Oxford NanoporeCentral Ltd. The licensee has exclusive rights to distribute this article, in any
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reads over 10 kb, and Jaffe showed a slide made by Oxford
Nanopore wherein the read length distribution was pre-
cisely overlapping with the fragment length distribution of
the library. (This is important because PacBio reads are on
average much shorter than the fragments that are read.)
The Oxford data had high error rates but more than 80%
of the reads had perfect 50-mer sections. Thus, these rela-
tively long, if error-prone, nanopore reads are a first
glimpse of what may yet come as these methods and base-
calling algorithms improve. Oxford Nanopore has clearly
achieved a technical tour de force, with the potential to
threaten PacBio’s dominance in the ultra-long-read field.
Is there room for more short-read technologies?
Hesaam Esfandyarpour from Genapsys (USA) thinks so.
He wants to put one or more of his lunchbox-sized devices
into every single laboratory. The Genapsys system involves
all-electronic detection of incorporation of nucleotides into
DNA clonally amplified on magnetic beads. These beads
are held above a regular array of electronic detectors. How-
ever, the presentation was nearly data-free, leaving the
audience craving more specifics regarding the mechanism
of signal generation, current throughput, cost, turn-around
time, read length, and error rate for this concept.
Sample preparation and analysis
Joshua Burton (University of Washington, USA) dis-
cussed analysis methods to take long-range sequence
information encoded in Hi-C data to provide an ultra-
long-range scaffold for the completion of de novo hu-
man genomes. The expected distribution of linked reads
seen in Hi-C rapidly decays as a function of linear se-
quence distance in the genome. Using an algorithm
named LACHESIS (after the Greek goddess who cut the
threads of life), they use a combination of data, includ-
ing Hi-C reads, to provide 99% accuracy in ordering
and orienting fragments into chromosome groups for
de novo human genome scaffolding.
Carlos Bustamante (Stanford University, USA) dis-
cussed a simple method for the enrichment of human
DNA reads from ancient DNA samples that are often
contaminated with environmental DNA. This method,
whole genome in-solution capture (WISC), uses whole
genome transcription with a fraction of biotynlated
rNTPs to create baits for the entire genome. These baits
can be used to enrich for human DNA, as well as to de-
plete human DNA in situations where bacterial or viral
DNA is the target of interest.
Applications: single cells, spatial sequencing and
DNA modifications
The age of single cell sequencing has arrived, and a
number of talks discussed methods and applications for
DNA and RNA sequencing from individual cells, therebylifting the veil on cell-to-cell variation hidden in the en-
semble average. Aviv Regev (Broad Institute, USA) dis-
cussed recent work deciphering the gene expression
variation in individual immune cells, and Steven Fodor
(Cellular Research, USA) described methods for quantifi-
cation of RNAs using molecular barcodes that allow
absolute quantification of transcript levels and avoid dis-
tortions due to PCR bias.
Paul Blainey (Broad Institute, USA) presented micro-
fluidic methods for generating libraries for whole gen-
ome sequences from hundreds of individual bacterial
cells. These reusable devices include on-chip sieve valves
and columns for the purification of samples. With sam-
ple preparation costs rapidly outstripping sequencing
costs - especially for bacterial genomes - his goal is to
generate an entire sequencing library from a bacterium
for roughly $1 total sample preparation costs, providing
a means for deep profiling the evolutionary landscape of
related cells, or whole genome-level analysis of environ-
mental organisms.
In a similar spirit to single cell sequencing, Patrik Ståhl
(Karolinska Institute, Sweden) described a method to
use sequencing to develop a rich spatial picture of gene
expression, thereby harnessing the immense power of
high-throughput sequencing to perform a kind of gene
expression microscopy. His method uses a microarray of
DNA to provide a spatial grid of DNA barcodes. These
barcodes were used to capture a panel of RNAs, which
were then sequenced using standard sequencing technol-
ogy. After sequencing, the barcodes allowed confident
assignment of sequenced transcripts to the location of
origin within the tissue slice. These data thus provided a
digital picture of the spatial organization of gene expres-
sion with near-cellular or subcellular resolution. However,
it appeared from these data that gene expression levels
were digital (for example, on or off) for each ‘pixel’ of the
microarray matrix, opening an exciting future possibility
of increased dynamic range.
Zak Wescoe from the Akeson laboratory at UCSC gave a
fascinating talk about discriminating DNA modifications
on the basis of conductance signals in a nanopore that is
similar to Oxford Nanopore technology. The ‘adapter’ en-
zyme that threads strands into the hemolysin pore is phi29
DNA polymerase (as opposed to the helicase apparently
used by Oxford Nanopore for sequencing). Wescoe tested
oligonucleotide constructs with different cytosine modifica-
tions (methyl-, hydroxymethyl-, formyl-, carboxyl-) and was
able to find signals that distinguished them from one an-
other, adding to the potential application space of nanopore
sensing.
Conclusions
As the sun set on the Florida coast at the close of AGBT
2014, a few points appeared clear: first, a battle was
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for the long-read sequencing market. Second, investiga-
tions of nucleic acids obtained from single cells have
moved from proof-of-concept to becoming a true driver
of biological discovery. Finally, as evidenced by the
wealth of presentations dealing with impressive bio-
logical applications (which we do not have sufficient
space to fully address here), sequencing has become a
standard method for attacking an array of complex bio-
logical questions. In brief, by transforming biology into
DNA space, then making billions of digital measure-
ments in reasonable amounts of time for reasonable
cost, high-throughput enables data sets that are well
matched to the underlying biological complexity. Thus,
sequencing technologies are not only rapidly bringing on
the age of the ‘personalized genome’, but are also driving
a revolution in biological sciences on the broadest scale.
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